In diffuse large B-cell lymphoma, early assessment of treatment response by 18F-FDG PET
may trigger treatment modification. Reliable identification of good and poor responders is …

Interim 18F-FDG PET (after 1–4 cycles of chemotherapy) may be useful for tailoring a risk-
adapted therapeutic strategy in lymphoma. The purpose of this study was to investigate …

The value of interim 18F-FDG PET/CT (iPET)–guided treatment decisions in patients with
diffuse large B-cell lymphoma (DLBCL) has been the subject of much debate. This …

This study investigated whether the reference background above which a residual mass is
considered positive in the International Harmonization Project criteria should be modified for …

Abstract Purpose Interim 18 F-FDG PET performed early during the course of therapy in
diffuse large B-cell lymphoma (DLBCL) is a good predictor of outcome. However …

The prognosis value of interim positron emission tomography (PET) remains controversial in
diffuse large B-cell lymphoma (DLBCL) patients because of the absence of consensus on …

Interim 18F-fluorodeoxyglucose positron emission tomography performed early during the
course of therapy in diffuse large B-cell lymphoma is highly predictive of outcome and now …

We aimed to determine the added value of baseline metabolic tumor volume (MTV) and
interim PET (I-PET) to the age-adjusted international prognostic index (aaIPI) to predict 2-y …

We aimed to assess the interobserver agreement of interim PET (I-PET) and end-of-
treatment PET (EoT-PET) using the Deauville score (DS) in first-line diffuse large B-cell …

The purpose of this study was to assess the prognostic value of early 18F-FDG PET using
standardized uptake value (SUV) compared with visual analysis in patients with diffuse large …